These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 27841133)

  • 21. Utility of positron emission tomography-computed tomography in identification of residual nodal disease after chemoradiation for advanced head and neck cancer.
    Gourin CG; Williams HT; Seabolt WN; Herdman AV; Howington JW; Terris DJ
    Laryngoscope; 2006 May; 116(5):705-10. PubMed ID: 16652075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oncologic effectiveness of selective neck dissection in the N0 irradiated neck.
    Solares CA; Fritz MA; Esclamado RM
    Head Neck; 2005 May; 27(5):415-20. PubMed ID: 15712298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recurrence rates after selective neck dissection in the N0 irradiated neck.
    Fritz MA; Esclamado RM; Lorenz RR; Wood BG; Lavertu P; Strome M
    Arch Otolaryngol Head Neck Surg; 2002 Mar; 128(3):292-5. PubMed ID: 11886346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nutritional management in head and neck cancer: United Kingdom National Multidisciplinary Guidelines.
    Talwar B; Donnelly R; Skelly R; Donaldson M
    J Laryngol Otol; 2016 May; 130(S2):S32-S40. PubMed ID: 27841109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI.
    Schöder H; Carlson DL; Kraus DH; Stambuk HE; Gönen M; Erdi YE; Yeung HW; Huvos AG; Shah JP; Larson SM; Wong RJ
    J Nucl Med; 2006 May; 47(5):755-62. PubMed ID: 16644744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective neck dissection following adjuvant therapy for advanced head and neck cancer.
    Mukhija V; Gupta S; Jacobson AS; Eloy JA; Genden EM
    Head Neck; 2009 Feb; 31(2):183-8. PubMed ID: 19031407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N2 disease in patients with head and neck squamous cell cancer treated with chemoradiotherapy: is there a role for posttreatment neck dissection?
    Cho AH; Shah S; Ampil F; Bhartur S; Nathan CO
    Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1112-8. PubMed ID: 19917924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deferring planned neck dissection following chemoradiation for stage IV head and neck cancer: the utility of PET-CT.
    Nayak JV; Walvekar RR; Andrade RS; Daamen N; Lai SY; Argiris A; Smith RP; Heron DE; Ferris RL; Johnson JT; Branstetter BF
    Laryngoscope; 2007 Dec; 117(12):2129-34. PubMed ID: 17921898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Controversies in surgical management of the node-positive neck after chemoradiation.
    Lango MN; Myers JN; Garden AS
    Semin Radiat Oncol; 2009 Jan; 19(1):24-8. PubMed ID: 19028342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of Salivary Gland Tumours: United Kingdom National Multidisciplinary Guidelines.
    Sood S; McGurk M; Vaz F
    J Laryngol Otol; 2016 May; 130(S2):S142-S149. PubMed ID: 27841127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of superselective and selective neck dissection for advanced nodal metastases after chemoradiation.
    Robbins KT; Doweck I; Samant S; Vieira F
    Arch Otolaryngol Head Neck Surg; 2005 Nov; 131(11):965-9. PubMed ID: 16301367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Planned neck dissection after concomitant radiochemotherapy for advanced head and neck cancer.
    Frank DK; Hu KS; Culliney BE; Persky MS; Nussbaum M; Schantz SP; Malamud SC; Holliday RA; Khorsandi AS; Sessions RB; Harrison LB
    Laryngoscope; 2005 Jun; 115(6):1015-20. PubMed ID: 15933512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+.
    Layland MK; Sessions DG; Lenox J
    Laryngoscope; 2005 Apr; 115(4):629-39. PubMed ID: 15805872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymph node staging.
    Vogl T; Bisdas S
    Top Magn Reson Imaging; 2007 Aug; 18(4):303-16. PubMed ID: 17893595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of neck dissection in the setting of chemoradiation therapy for head and neck squamous cell carcinoma with advanced neck disease.
    Hamoir M; Ferlito A; Schmitz S; Hanin FX; Thariat J; Weynand B; Machiels JP; Grégoire V; Robbins KT; Silver CE; Strojan P; Rinaldo A; Corry J; Takes RP
    Oral Oncol; 2012 Mar; 48(3):203-10. PubMed ID: 22104248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neck lymph node metastases from unknown primary.
    Arosio AD; Pignataro L; Gaini RM; Garavello W
    Cancer Treat Rev; 2017 Feb; 53():1-9. PubMed ID: 28027480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of contralateral N0 neck in pyriform sinus carcinoma.
    Koo BS; Lim YC; Lee JS; Kim YH; Kim SH; Choi EC
    Laryngoscope; 2006 Jul; 116(7):1268-72. PubMed ID: 16826073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of CT and ¹⁸F-FDG PET in managing the neck in node-positive head and neck cancer after chemoradiotherapy.
    Inohara H; Enomoto K; Tomiyama Y; Yoshii T; Osaki Y; Higuchi I; Inoue T; Hatazawa J
    Acta Otolaryngol; 2009 Aug; 129(8):893-9. PubMed ID: 18839385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prevalence of lymph node metastases in clinically N0 necks with oral cavity squamous cell carcinoma: is CT good enough for nodal staging?
    Furukawa M; Dillon JK; Futran ND; Anzai Y
    Acta Radiol; 2014 Jun; 55(5):570-8. PubMed ID: 23963150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemotherapy: United Kingdom National Multidisciplinary Guidelines.
    Kelly CG
    J Laryngol Otol; 2016 May; 130(S2):S71-S74. PubMed ID: 27841142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.